-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – HD-6277 in Type 2 Diabetes
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - HD-6277 in Type 2 Diabetes report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. HD-6277 in Type 2 Diabetes Drug Details: HD-6277 is under development...
-
Product Insights
Hinds Lake (main) (HD-1)
Hinds Lake (main) (HD-1) is a Hydro project located in Newfoundland and Labrador, Canada. The project is owned by Newfoundland and Labrador Hydro. The project came online in 1980. Empower your strategies with our Hinds Lake (main) (HD-1) report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of the report...
-
Sector Analysis
Oil and Gas Industry Annual Contracts Analytics by Region, Sector, Planned and Awarded Contracts and Top Contractors
Oil and Gas Industry Contracts Review Report Overview The oil and gas industry reported more than 5,915 contracts during Q4 2023. The Oil and Gas Industry Contracts Review Report provides a count of the industry contracts by region, including a sector-wise update of Q4 2023. The report also discusses the terrain and scope types in the industry along with the key contractors & issuers making the oil and gas industry contracts. Key Sectors ·       Upstream ·       Downstream/petrochemical ·       Midstream Key...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Bevacizumab Biosimilar in Non-Small Cell Lung Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Bevacizumab Biosimilar in Non-Small Cell Lung Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Bevacizumab Biosimilar in Non-Small Cell Lung Cancer Drug Details:...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Aflibercept in Graves’ Ophthalmopathy
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Aflibercept in Graves' Ophthalmopathy report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Aflibercept in Graves' Ophthalmopathy Drug Details: Aflibercept (Eylea / Eylea HD) is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Aflibercept in Retinopathy
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Aflibercept in Retinopathy report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Aflibercept in Retinopathy Drug Details: Aflibercept (Eylea / Eylea HD) is a recombinant...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Aflibercept in Optic Neuropathy
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Aflibercept in Optic Neuropathy report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Aflibercept in Optic Neuropathy Drug Details: Aflibercept (Eylea / Eylea HD) is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Sargramostim in Hematopoietic Stem Cell Transplantation
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Sargramostim in Hematopoietic Stem Cell Transplantation report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Sargramostim in Hematopoietic Stem Cell Transplantation Drug Details: Sargramostim...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Sargramostim in Non-Small Cell Lung Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Sargramostim in Non-Small Cell Lung Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Sargramostim in Non-Small Cell Lung Cancer Drug Details: Sargramostim (Leukine,...